David Lemus
Director/Board Member at SCILEX HOLDING COMPANY
Net worth: 20 077 $ as of 30/04/2024
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Henry Ji | M | 59 |
Scilex, Inc.
 Scilex, Inc. Pharmaceuticals: MajorHealth Technology Scilex, Inc. engages in the acquisition, development, and commercialization of non-opioid pain management products for the treatment of acute and chronic pain. The company is headquartered in Paolo Alto, CA. | 35 years |
| Dorman Followwill | M | 60 |
Scilex, Inc.
Scilex, Inc. Pharmaceuticals: MajorHealth Technology Scilex, Inc. engages in the acquisition, development, and commercialization of non-opioid pain management products for the treatment of acute and chronic pain. The company is headquartered in Paolo Alto, CA. | 7 years |
| Stephen Ma | M | 51 | 2 years | |
| Jaisim Shah | M | 63 | 11 years | |
| Craig Tooman | M | 58 | 3 years | |
| Brian Cooley | M | - | - | |
| Jarrod Borkat | M | - |
Biohealth Innovation, Inc.
 Biohealth Innovation, Inc. Financial ConglomeratesFinance Biohealth Innovation, Inc. sources and evaluates market-relevant bioheath intellectual properties, connects the IP with funding, and assists businesses in marketing and growth. It is a regional innovation intermediary that accelerates and facilitates technology transfer and commercialization of market-relevant research in federal labs, universities, and biohealth companies in the Region. The company was founded in 2011 and is headquartered in Rockville, MD. | - |
| Alexis Nahama | M | - | 7 years | |
| Yue Wu | M | 62 | 8 years | |
| Gerd Zettlmeissl | M | 68 | 7 years | |
| Richard Bendis | M | 77 |
Biohealth Innovation, Inc.
Biohealth Innovation, Inc. Financial ConglomeratesFinance Biohealth Innovation, Inc. sources and evaluates market-relevant bioheath intellectual properties, connects the IP with funding, and assists businesses in marketing and growth. It is a regional innovation intermediary that accelerates and facilitates technology transfer and commercialization of market-relevant research in federal labs, universities, and biohealth companies in the Region. The company was founded in 2011 and is headquartered in Rockville, MD. | 12 years |
| Tommy Thompson | M | 81 |
Scilex, Inc.
Scilex, Inc. Pharmaceuticals: MajorHealth Technology Scilex, Inc. engages in the acquisition, development, and commercialization of non-opioid pain management products for the treatment of acute and chronic pain. The company is headquartered in Paolo Alto, CA. | 2 years |
| Marie Wikström Lindholm | M | - | 7 years | |
| Shawn Sahebi | M | - | - | |
| Ronald Scott | M | 69 | 7 years | |
| Julia Neugebauer | M | - | 18 years | |
| Yesenia D'Alessandro | F | - |
Biohealth Innovation, Inc.
Biohealth Innovation, Inc. Financial ConglomeratesFinance Biohealth Innovation, Inc. sources and evaluates market-relevant bioheath intellectual properties, connects the IP with funding, and assists businesses in marketing and growth. It is a regional innovation intermediary that accelerates and facilitates technology transfer and commercialization of market-relevant research in federal labs, universities, and biohealth companies in the Region. The company was founded in 2011 and is headquartered in Rockville, MD. | 8 years |
| Craig S. Lewis | M | - |
Ironshore Pharmaceuticals (America), Inc.
 Ironshore Pharmaceuticals (America), Inc. Pharmaceuticals: MajorHealth Technology Part of Ironshore Therapeutics, Inc., Ironshore Pharmaceuticals (America), Inc. manufactures pharmaceutical products. | 9 years |
| Gem Hopkins | M | - | 4 years | |
| Charles J. Morton | M | - |
Biohealth Innovation, Inc.
Biohealth Innovation, Inc. Financial ConglomeratesFinance Biohealth Innovation, Inc. sources and evaluates market-relevant bioheath intellectual properties, connects the IP with funding, and assists businesses in marketing and growth. It is a regional innovation intermediary that accelerates and facilitates technology transfer and commercialization of market-relevant research in federal labs, universities, and biohealth companies in the Region. The company was founded in 2011 and is headquartered in Rockville, MD. | 10 years |
| Amanda Wilson | F | - |
Biohealth Innovation, Inc.
Biohealth Innovation, Inc. Financial ConglomeratesFinance Biohealth Innovation, Inc. sources and evaluates market-relevant bioheath intellectual properties, connects the IP with funding, and assists businesses in marketing and growth. It is a regional innovation intermediary that accelerates and facilitates technology transfer and commercialization of market-relevant research in federal labs, universities, and biohealth companies in the Region. The company was founded in 2011 and is headquartered in Rockville, MD. | - |
| Pete Briskman | M | - |
Biohealth Innovation, Inc.
Biohealth Innovation, Inc. Financial ConglomeratesFinance Biohealth Innovation, Inc. sources and evaluates market-relevant bioheath intellectual properties, connects the IP with funding, and assists businesses in marketing and growth. It is a regional innovation intermediary that accelerates and facilitates technology transfer and commercialization of market-relevant research in federal labs, universities, and biohealth companies in the Region. The company was founded in 2011 and is headquartered in Rockville, MD. | - |
| Mike A. Royal | M | 70 | 10 years | |
| Steve Lincoln | M | - | - | |
| Antoinette Hiebeler-Hasner | F | 66 | 8 years | |
| Steven Romano | M | 64 | 5 years | |
| Kim D. Janda | M | 67 | 12 years | |
| Rhonda L. Hellums | F | 52 | 3 years | |
| Linnea Corwin Elrington | F | - | 7 years | |
| Ron Kurz | M | - |
Biohealth Innovation, Inc.
Biohealth Innovation, Inc. Financial ConglomeratesFinance Biohealth Innovation, Inc. sources and evaluates market-relevant bioheath intellectual properties, connects the IP with funding, and assists businesses in marketing and growth. It is a regional innovation intermediary that accelerates and facilitates technology transfer and commercialization of market-relevant research in federal labs, universities, and biohealth companies in the Region. The company was founded in 2011 and is headquartered in Rockville, MD. | - |
| Eric Fink | M | - | 2 years | |
| Scott Evangelista | M | - |
Ironshore Pharmaceuticals (America), Inc.
Ironshore Pharmaceuticals (America), Inc. Pharmaceuticals: MajorHealth Technology Part of Ironshore Therapeutics, Inc., Ironshore Pharmaceuticals (America), Inc. manufactures pharmaceutical products. | - |
| Lewis Warrington | M | - |
Ironshore Pharmaceuticals (America), Inc.
Ironshore Pharmaceuticals (America), Inc. Pharmaceuticals: MajorHealth Technology Part of Ironshore Therapeutics, Inc., Ironshore Pharmaceuticals (America), Inc. manufactures pharmaceutical products. | - |
| Danny Villeneuve | M | - |
Ironshore Pharmaceuticals (America), Inc.
Ironshore Pharmaceuticals (America), Inc. Pharmaceuticals: MajorHealth Technology Part of Ironshore Therapeutics, Inc., Ironshore Pharmaceuticals (America), Inc. manufactures pharmaceutical products. | - |
| Steven Roberts | M | - |
Biohealth Innovation, Inc.
Biohealth Innovation, Inc. Financial ConglomeratesFinance Biohealth Innovation, Inc. sources and evaluates market-relevant bioheath intellectual properties, connects the IP with funding, and assists businesses in marketing and growth. It is a regional innovation intermediary that accelerates and facilitates technology transfer and commercialization of market-relevant research in federal labs, universities, and biohealth companies in the Region. The company was founded in 2011 and is headquartered in Rockville, MD. | - |
| J.P. Gabriel | M | - | 1 years | |
| Ray Blanchard | M | - |
Biohealth Innovation, Inc.
Biohealth Innovation, Inc. Financial ConglomeratesFinance Biohealth Innovation, Inc. sources and evaluates market-relevant bioheath intellectual properties, connects the IP with funding, and assists businesses in marketing and growth. It is a regional innovation intermediary that accelerates and facilitates technology transfer and commercialization of market-relevant research in federal labs, universities, and biohealth companies in the Region. The company was founded in 2011 and is headquartered in Rockville, MD. | - |
| Michael Friedlander | M | - |
Biohealth Innovation, Inc.
Biohealth Innovation, Inc. Financial ConglomeratesFinance Biohealth Innovation, Inc. sources and evaluates market-relevant bioheath intellectual properties, connects the IP with funding, and assists businesses in marketing and growth. It is a regional innovation intermediary that accelerates and facilitates technology transfer and commercialization of market-relevant research in federal labs, universities, and biohealth companies in the Region. The company was founded in 2011 and is headquartered in Rockville, MD. | - |
| Tyrell J. Rivers | M | 51 |
Biohealth Innovation, Inc.
Biohealth Innovation, Inc. Financial ConglomeratesFinance Biohealth Innovation, Inc. sources and evaluates market-relevant bioheath intellectual properties, connects the IP with funding, and assists businesses in marketing and growth. It is a regional innovation intermediary that accelerates and facilitates technology transfer and commercialization of market-relevant research in federal labs, universities, and biohealth companies in the Region. The company was founded in 2011 and is headquartered in Rockville, MD. | - |
| Thomas Curatolo | M | - |
Ironshore Pharmaceuticals (America), Inc.
Ironshore Pharmaceuticals (America), Inc. Pharmaceuticals: MajorHealth Technology Part of Ironshore Therapeutics, Inc., Ironshore Pharmaceuticals (America), Inc. manufactures pharmaceutical products. | 9 years |
| Jay A. Perman | M | - |
Biohealth Innovation, Inc.
Biohealth Innovation, Inc. Financial ConglomeratesFinance Biohealth Innovation, Inc. sources and evaluates market-relevant bioheath intellectual properties, connects the IP with funding, and assists businesses in marketing and growth. It is a regional innovation intermediary that accelerates and facilitates technology transfer and commercialization of market-relevant research in federal labs, universities, and biohealth companies in the Region. The company was founded in 2011 and is headquartered in Rockville, MD. | - |
| Suresh K. Khemani | M | 64 | - | |
| Kenneth Carter | M | 65 |
Biohealth Innovation, Inc.
Biohealth Innovation, Inc. Financial ConglomeratesFinance Biohealth Innovation, Inc. sources and evaluates market-relevant bioheath intellectual properties, connects the IP with funding, and assists businesses in marketing and growth. It is a regional innovation intermediary that accelerates and facilitates technology transfer and commercialization of market-relevant research in federal labs, universities, and biohealth companies in the Region. The company was founded in 2011 and is headquartered in Rockville, MD. | - |
| Donna J. Edmonds | F | - |
Biohealth Innovation, Inc.
Biohealth Innovation, Inc. Financial ConglomeratesFinance Biohealth Innovation, Inc. sources and evaluates market-relevant bioheath intellectual properties, connects the IP with funding, and assists businesses in marketing and growth. It is a regional innovation intermediary that accelerates and facilitates technology transfer and commercialization of market-relevant research in federal labs, universities, and biohealth companies in the Region. The company was founded in 2011 and is headquartered in Rockville, MD. | - |
| James Ede-Golightly | M | 44 | 5 years | |
| Aimee Smart | F | - |
Biohealth Innovation, Inc.
Biohealth Innovation, Inc. Financial ConglomeratesFinance Biohealth Innovation, Inc. sources and evaluates market-relevant bioheath intellectual properties, connects the IP with funding, and assists businesses in marketing and growth. It is a regional innovation intermediary that accelerates and facilitates technology transfer and commercialization of market-relevant research in federal labs, universities, and biohealth companies in the Region. The company was founded in 2011 and is headquartered in Rockville, MD. | - |
| Mark R. Brunswick | M | - | 7 years | |
| Steven W. Hutcheson | M | 70 |
University of Maryland
| 40 years |
| Daniel O'Day | M | 59 |
Pharmaceutical Manufacturers Association of America
| - |
| Suketu D. Desai | M | 59 | - | |
| Barbara Krebs-Pohl | M | - | 26 years | |
| Eric Floyd | M | 62 | 5 years | |
| Klaus de Wall | M | - | 19 years | |
| Ralf Ostendorp | M | - | 25 years | |
| Todd Chappell | M | - |
Biohealth Innovation, Inc.
Biohealth Innovation, Inc. Financial ConglomeratesFinance Biohealth Innovation, Inc. sources and evaluates market-relevant bioheath intellectual properties, connects the IP with funding, and assists businesses in marketing and growth. It is a regional innovation intermediary that accelerates and facilitates technology transfer and commercialization of market-relevant research in federal labs, universities, and biohealth companies in the Region. The company was founded in 2011 and is headquartered in Rockville, MD. | 10 years |
| Christopher Callaghan | M | - |
Biohealth Innovation, Inc.
Biohealth Innovation, Inc. Financial ConglomeratesFinance Biohealth Innovation, Inc. sources and evaluates market-relevant bioheath intellectual properties, connects the IP with funding, and assists businesses in marketing and growth. It is a regional innovation intermediary that accelerates and facilitates technology transfer and commercialization of market-relevant research in federal labs, universities, and biohealth companies in the Region. The company was founded in 2011 and is headquartered in Rockville, MD. | - |
| John A. Sackett | M | - |
Biohealth Innovation, Inc.
Biohealth Innovation, Inc. Financial ConglomeratesFinance Biohealth Innovation, Inc. sources and evaluates market-relevant bioheath intellectual properties, connects the IP with funding, and assists businesses in marketing and growth. It is a regional innovation intermediary that accelerates and facilitates technology transfer and commercialization of market-relevant research in federal labs, universities, and biohealth companies in the Region. The company was founded in 2011 and is headquartered in Rockville, MD. | - |
| Dmitri V. Lissin | M | 55 | - | |
| Rick Nullmeier | M | - |
Ironshore Pharmaceuticals (America), Inc.
Ironshore Pharmaceuticals (America), Inc. Pharmaceuticals: MajorHealth Technology Part of Ironshore Therapeutics, Inc., Ironshore Pharmaceuticals (America), Inc. manufactures pharmaceutical products. | 9 years |
| Anthony Lakavage | M | - |
Biohealth Innovation, Inc.
Biohealth Innovation, Inc. Financial ConglomeratesFinance Biohealth Innovation, Inc. sources and evaluates market-relevant bioheath intellectual properties, connects the IP with funding, and assists businesses in marketing and growth. It is a regional innovation intermediary that accelerates and facilitates technology transfer and commercialization of market-relevant research in federal labs, universities, and biohealth companies in the Region. The company was founded in 2011 and is headquartered in Rockville, MD. | - |
| Juan Carlos Lopez | M | - |
Biohealth Innovation, Inc.
Biohealth Innovation, Inc. Financial ConglomeratesFinance Biohealth Innovation, Inc. sources and evaluates market-relevant bioheath intellectual properties, connects the IP with funding, and assists businesses in marketing and growth. It is a regional innovation intermediary that accelerates and facilitates technology transfer and commercialization of market-relevant research in federal labs, universities, and biohealth companies in the Region. The company was founded in 2011 and is headquartered in Rockville, MD. | - |
| Curtis Rambaran | M | - | 3 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Elizabeth Czerepak | F | 58 |
Scilex, Inc.
Scilex, Inc. Pharmaceuticals: MajorHealth Technology Scilex, Inc. engages in the acquisition, development, and commercialization of non-opioid pain management products for the treatment of acute and chronic pain. The company is headquartered in Paolo Alto, CA. | 2 years |
| Laura Hamill | F | 60 |
Scilex, Inc.
Scilex, Inc. Pharmaceuticals: MajorHealth Technology Scilex, Inc. engages in the acquisition, development, and commercialization of non-opioid pain management products for the treatment of acute and chronic pain. The company is headquartered in Paolo Alto, CA. | 1 years |
| Tien-Li Lee | M | 49 |
Scilex, Inc.
Scilex, Inc. Pharmaceuticals: MajorHealth Technology Scilex, Inc. engages in the acquisition, development, and commercialization of non-opioid pain management products for the treatment of acute and chronic pain. The company is headquartered in Paolo Alto, CA. | 4 years |
| Gregg Lapointe | M | 65 |
Leadiant Biosciences, Inc.
 Leadiant Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Leadiant Biosciences, Inc. operates as a research-based pharmaceutical company. It develops and commercializes medicines for rare diseases. The company was founded in 1989 by Claudio Cavazza and is headquartered in Gaithersburg, MD. | 11 years |
| Mark Rothera | M | 61 | 2 years | |
| Bill Wainger | M | - |
University of Maryland
| 6 years |
| Andrew Richards | M | 64 | 3 years | |
| George Ng | M | 49 | 4 years | |
| David J. Ellam | M | - | 3 years | |
| Stephen Parker | M | 65 | 6 years | |
| Daniel Camus | M | 70 | 12 years | |
| Metin Colpan | M | 69 | 8 years | |
| Robert Quinn | M | 41 | 4 years | |
| Walter Blättler | M | 75 | 8 years | |
| Robert Knight | M | 73 | 3 years | |
| Markus Dangl | M | - | - | |
| Alistair Gray | M | 75 | 9 years | |
| Ralph L. Lary | M | - |
University of Maryland
| 7 years |
| Markus Enzelberger | M | 55 | 18 years | |
| Ernst-Ludwig Winnacker | M | 82 | 22 years | |
| Annalisa Jenkins | M | 58 | 1 years | |
| Michael Dalpee | M | - |
University of Maryland
| 3 years |
| Giles Campion | M | 69 | 4 years | |
| Edgar Lee | M | 48 | 1 years | |
| David Deming | M | 71 | 3 years | |
| William J. Schroeder | M | - |
University of Maryland
| 4 years |
| David Solomon | M | 63 | 2 years | |
| Andrew Charles Palmer | M | - |
University of Maryland
| 7 years |
| Robin Smith | M | 59 | 2 years | |
| Jerome Zeldis | M | 74 | 3 years | |
| Robert Wasilewski | M | - |
University of Maryland
| 4 years |
| Andreas Plückthun | M | 65 | 15 years | |
| Stanley P. Kinder | M | - |
University of Maryland
| 14 years |
| Frank Mathias | M | 62 | 13 years | |
| Shai Schiller | M | - |
University of Maryland
| 7 years |
| Jürgen Drews | M | 91 | 14 years | |
| Geoffrey Nicholas Vernon | M | 72 | 16 years | |
| Najjam Asghar | M | 43 | 3 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 63 | 63.00% |
| United Kingdom | 20 | 20.00% |
| Germany | 17 | 17.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- David Lemus
- Personal Network
